Micra™ AV2 and Micra™ VR2 leadless pacemakers are the world’s smallest pacemakers1 for bradyarrhythmia management.
To view the indications, safety, and warnings, scroll down or click on one of the links below to jump you down the page to that product.
Micra™ AV2 and Micra™ VR2 provide an unmatched leadless pacing experience for bradycardia patients. With improved battery longevity and smarter algorithms, most patients are projected to only need one device for life.2
The updated delivery system now has a rounded catheter tip with more surface area to decrease tip pressure during device implant.3 Micra™ AV2 and Micra™ VR2 devices are implanted with the same streamlined procedure that has been utilized by over 10,000 trained Micra™ physicians worldwide.4
Medtronic is following more than 30,000 patients in clinical research activities for Micra™ leadless pacemakers. Additionally, there have been more than 250 manuscripts published across the globe.4 Visit Medtronic Academy to learn more about our robust evidence.
> 99%
Implant success rate across multiple clinical studies.5–7
↓ 53%
Reduction in both major complications and system revisions through three years.†,8
< 5%
Low rates of major complications and system revisions sustained through five years.†,8
† Versus transvenous — Data shown refer only to Micra™ VR.
